Bio Innovation Conference | 2021 Speakers
Presented by Maryland Life Sciences, a division of the Maryland Tech Council, the Bio Innovation Conference is driving the future of life sciences in Maryland. This conference provides a forum for professionals from industry, academia and government to discuss trends and insight into Maryland’s burgeoning life sciences industry and topics related to funding, structuring, commercialization and government relations.
Maryland Life Sciences Bio Innovation Conference, Bio Innovation Conference, Maryland, life sciences, biotechnology, Maryland Tech Council, bio, innovation, conference, Maryland Life Sciences, Bio Innovation Conference, vaccines, gene therapy, networking, Washington DC, DMV, Biohealth, biohealth capital region, sciences, entrepreneurship, entrepreneur, startup, Maryland Life Sciences Bio Innovation Conference, Maryland Tech Council Conference, annual conference
page-template,page-template-full_width,page-template-full_width-php,page,page-id-20088,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive

2021 Speakers

save the date • October 4-5, 2022

Conference Speakers

Dr. David Agus
Chief Executive Officer, Ellison Institute, physician, author, CBS Medical Contributor

Sally Allain

Head, Johnson & Johnson
Innovation – JLABS @
Washington, DC | BLUE

David Anderson
Senior Director,
Quality Site Head
Kite, a Gilead Company

Austin, MD

Chief Executive Officer-Partner
Flagship Pioneering

Gary Disbrow, PhD
Director, Deputy Assistant Secretary for Preparedness and Response, BARDA
U.S. Department of Health and Human Services

Suk See DeRavin
Clinician, Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH

Desiderio, PhD

Director, BioHealth and Life Sciences, Department of Commerce

Doug Doerfler
President and Chief Executive Officer

Dr. Lisa Dunkle
Vice President, Clinical Development
Global Medical Lead

Bill Enright
Chief Executive Officer

Catherine Hanley
Vice President and Interim CDMO Business Unit Head, Emergent BioSolutions

Matthew Hewitt
B.A, PhD

Senior Director, Scientific Solutions, Cell and Gene Therapy, Charles River Labs

Hepburn, MD

Director, COVID Vaccine Development, HHS-DoD Countermeasures Acceleration Group

Jeffrey Hung
General Manager
Vigene Biosciences

Jim Jackson
Vice President, Manufacturing Operations and Site Head, Kite, a Gilead Company

Murat Kalayoglu, M.D., Ph.D.
President & Chief Executive Officer, Cartesian Therapeutics

Kazem Kazempour
President and Chief Executive Officer, Amarex Clinical Research

Mike Klichinsky
Co-Founder and Senior Vice President, Research
Carisma Therapeutics

Dr. Bruce Levy
Chief of Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Harvard Medical School

Beth Maloney
President, Palladian Partners, Inc., an Altarum Company

Craig Malzahn
Vice President, Technical Operations

Sarah Meeks
Senior Vice President,
Business Development

Dr. Tahseen Mozaffar
Professor, Neurology and Laboratory Medicine, University of California, Irvine

Michael Nestor, Ph.D.
Scientific Engagement Lead, Johnson & Johnson Innovation – JLABS @ Washington, DC

Peter Olagunju
Chief Technology Officer
TCR2 Therapeutics

Nicholas Ostrout
Global Head of Commercial Development

Martin Rosendale
Chief Executive Officer,
Maryland Life Sciences

KaShauna Rohlehr, MBA, PMP
Associate Director – Alliance, Program and Project Management, GSK

Jon Rowley, PhD
Chief Product Officer

Joseph Sanchez
Director, Science Engagement & STEM Programming, R&D North America, AstraZeneca

Harish Santhanum
Senior Director, Manufacturing Science and Technology
Kite, a Gilead Company

Melanie Saville
Director of R&D, Coalition for Epidemic Preparedness Innovations

Kelly Schulz
Maryland Department of Commerce

Michael Singer

Chief Scientific Officer
Cartesian Therapeutics

Brian Stamper
Senior Director of Manufacturing, Kite, a Gilead Company

Brad Stewart
Senior Vice President of Business Development, Montgomery County Economic Development Corporation

Ben Skowronski
Senior Director, Maryland Office Lead, Associate

Silvia Taylor
Senior Vice President, Global Corporate Affairs and Investor Relations, Novavax

Stephen Thomas
Professor, Health Policy & Management, Director, Maryland Center for Health Equity, University of Maryland

Robert van den Berg, PhD, MBA
Head of the Data Sciences & Computational Vaccinology Group, GSK

Thomas VanCott, PhD
Global Head of Product Development, Cell and Gene Therapy, Catalent Biologics

Steven Walker
Senior Director, Global Marketing – Early Portfolio Strategy, GSK

Nicole Wood
Senior Regional Director, State Advocacy